Dr James Herbert-Read is an Associate Professor and Whitten Lecturer in Marine Biology at the Department of Zoology, University of Cambridge. He serves as Deputy Head of Department (Postgraduate Education) and leads the Marine Behavioural Ecology Group. His research focuses on understanding how animals, particularly marine organisms, collect and process information from their environments to make behavioral decisions, with emphasis on social interactions, adaptation mechanisms, and ecological constraints. His group employs theoretical frameworks, controlled experiments, and quantitative field studies to investigate behavioral diversity in marine species. Key themes include collective behavior, predator-prey dynamics, camouflage strategies, and the impacts of environmental stressors on animal decision-making. Recent publications highlight work on lionfish vocalization mechanisms, cuttlefish camouflage, citizen science applications in marine research, and behavioral responses to visual and acoustic noise. Scientific awards and affiliations include: Whitten Lecturer in Marine Biology Associate Professor, University of Cambridge He has supervised research projects on topics such as: Social attraction in invasive fish species Evolution of coordinated movement Neurophysiological basis for leadership in shoals Maternal effects on offspring exploration
Georg Fantner is an Associate Professor at the Swiss Federal Institute of Technology Lausanne (EPFL) with dual appointments in the School of Engineering (STI) within the Institute of Bioengineering and the School of Life Sciences (SV) for teaching. He directs the Laboratory for Bio- and Nano-Instrumentation (LBNI) and holds leadership roles including President of the Open Science Strategic Committee and the Association des Professeurs de l'EPFL. Research Focus: Bioinstrumentation, Nanotechnology, Scanning Probe Microscopy, and Metrology Teaching: Structural Mechanics for Life Sciences, Metrology, and Metrology Practicals His research pioneers advanced instrumentation for nanoscale characterization, emphasizing data-driven approaches to enhance microscopy techniques. Recent work integrates deep learning with scanning probe microscopy for real-time biological imaging and develops novel MEMS devices for fluid-compatible nanoscale manipulation. Key innovations include hermetically sealed sample chambers for pathogen studies and deterministic nanotopography engineering. Professor Fantner actively mentors 7 current PhD students and has supervised 14 graduates. His laboratory fosters interdisciplinary collaboration across engineering, physics, and life sciences to advance nanoscale measurement technologies and instrumentation development.
Michael Levin is a Vannevar Bush Professor and Distinguished Professor at Tufts University, affiliated with the School of Arts and Sciences (Department of Biology) and School of Engineering (Biomedical Engineering). His research focuses on bioelectricity, developmental biology, and collective intelligence. He leads the Allen Discovery Center and the Tufts Center for Developmental and Regenerative Biology. Education: PhD in Genetics from Harvard Medical School (1996); BS in Computer Science and Biology from Tufts University (1992). Research Interests: Integrates developmental biology, computer science, and cognitive science to study morphogenesis, regeneration, and cancer. Explores bioelectric signaling, synthetic organisms, and AI-driven discovery. Key areas include regenerative medicine, cancer reprogramming, and collective intelligence in biological systems. Publications: Over 600 articles, with recent work on xenobots, neuroevolution, and bioelectric therapies. Themes include bioelectric control of form, AI in biology, and collective intelligence. Awards: INNS Donald O. Hebb Award, AAAS Fellow, and Vox Future Perfect 50 List recognition. Frequently invited to speak at conferences on biology, AI, and consciousness. Advising & Labs: Mentored numerous postdocs and students, including pioneers in bioelectricity and synthetic biology. Lab focuses on interdisciplinary approaches to biological pattern formation and regeneration.
Regina Ragan is a Professor in the Department of Materials Science and Engineering at the Samueli School of Engineering, University of California, Irvine. Her research focuses on nanomaterials, self-assembly, and surface-enhanced Raman scattering (SERS) for applications in optical communication, energy systems, and biomedical diagnostics. Education: Ph.D. in Applied Physics, California Institute of Technology, 2002 M.S. in Applied Physics, California Institute of Technology, 1998 B.S. in Materials Science and Engineering, University of California, Los Angeles, 1996 Her work integrates scanning probe microscopy and first-principles calculations to study thermodynamic driving forces in self-assembly and structure-function relationships. Recent publications highlight applications in antimicrobial susceptibility testing, environmental monitoring, and plasmonic device fabrication. The Ragan group develops low-cost diagnostic tools using SERS for telemedicine applications. Current lab members include graduate students and postdoctoral researchers working on nanoscale systems from atomic to mesoscale. Scientific Awards: NSF CAREER Award for fundamental studies of biological/inorganic interfaces Research Trends: Recent articles show a focus on SERS-based diagnostics, plasmonic nanoantennas, machine learning-assisted spectral analysis, and scalable synthesis of 3D graphene architectures. Subfields span quantum plasmonics, stress-activated materials, and biofilm monitoring.
Eric W. Schmidt is a Distinguished Professor of Medicinal Chemistry at the University of Utah, with adjunct appointments in Biological Sciences and Chemistry. His research focuses on natural products chemistry, biosynthesis, synthetic biology, and pharmaceutical applications of marine animal microbiomes. University of California, San Diego (BS, PhD) Research areas include: Biosynthesis in animals and their microbiomes Synthetic biology approaches to chemical engineering Drug design from marine natural products Metagenomic analysis of symbiotic relationships Neuroactive compound discovery Antibiotic development against resistant pathogens His lab has pioneered methods for: Biosynthetic gene cluster identification Heterologous expression in E. coli Enzymatic modification of peptides Chemical analysis of marine invertebrates Recent publications highlight discoveries in: Marine animal chemical defense mechanisms Evolution of biosynthetic pathways Antibiotic resistance profiling Ionic channel-targeting compounds Peptide macrocyclization techniques Lipid-polyketide biosynthesis continuum Email: ews1@utah.edu Honors include: Distinguished Professor recognition
Feng Feng is an Assistant Professor in the Department of Biochemistry and Molecular Biology at Oklahoma State University, where he has been employed since August 2020. His research focuses on understanding how plants interact with microbial communities in their rhizosphere under various environmental conditions. Dr. Feng received his Ph.D. in Plant Molecular Biology from Tsinghua University in Beijing, China (2008-2012), followed by an M.S. in Microbiology and B.S. in Biotechnology from Henan Agricultural University in Zhengzhou, China. Ph.D., Plant Molecular Biology, Tsinghua University, Beijing, China (2008-2012) M.S., Microbiology, Henan Agricultural University, Zhengzhou, China (2005-2008) B.S., Biotechnology, Henan Agricultural University, Zhengzhou, China (2001-2005) Dr. Feng's research interests center on plant-microbe interactions, particularly how plants balance immunity and symbiosis signaling pathways when encountering both pathogenic and beneficial microbes in the rhizosphere. His work examines how environmental conditions affect plant decisions to promote or inhibit microbial colonization, with the goal of developing cropping systems that require less chemical fertilizer and are more resilient to climate change. Using molecular, cell biology, genetic, and biochemical approaches, his lab investigates how abiotic environmental factors regulate plant-microbe interactions and how immunity and symbiosis signaling pathways influence broader microbial communities. Dr. Feng's scholarly output shows a consistent focus on plant immunity and symbiosis mechanisms, particularly involving LysM receptor-like kinases and their role in distinguishing between pathogenic and symbiotic microbial signals. His recent work has increasingly emphasized the ecological context of plant-microbe interactions and the potential applications for sustainable agriculture. Dr. Feng serves as an Associate Editor for Frontiers in Microbiology (since 2022) and has editorial roles with several other journals including Frontiers in Plant Science, Horticultural Plant Journal, and iMeta. Associate Editor, Frontiers in Microbiology (2022-present) Editorial Board, Frontiers in Plant Science (2021-present) Editorial Board, Horticultural Plant Journal (2021-present) Editorial Board, iMeta (2021-present) Dr. Feng actively mentors graduate students and postdoctoral researchers, with his lab currently recruiting Ph.D. students and postdocs interested in plant-microbe interactions. He has secured multiple research grants including funding from the U.S. Department of Agriculture and the Oklahoma Center for the Advancement of Science and Technology (OCAST). His laboratory investigates the molecular mechanisms by which plants regulate their interactions with rhizosphere communities, with particular focus on how environmental conditions influence the balance between immunity and symbiosis signaling pathways.
Nicolas Thomä is a Full Professor and head of the Thomä Lab at the École Polytechnique Fédérale de Lausanne (EPFL), where he holds the Paternot Chair in Cancer Research. He is affiliated with the School of Life Sciences (SV) and the Institute of Chemical and Biological Technology (ISREC), leading the UPTHOMAE research unit. His work bridges structural biology, chemical biology, and cancer research, with a focus on transcriptional regulation and targeted protein degradation. His research interests center on chromatin biology and the molecular mechanisms by which transcription factors access gene promoters within chromatin. He investigates how multi-protein complexes regulate gene expression, particularly focusing on the role of E3 ubiquitin ligases and molecular glues in targeted protein degradation. His lab combines structural techniques (including cryo-EM), biochemical assays, and functional genomics to unravel how small molecules can rewire protein interactions and induce degradation of disease-relevant proteins, especially transcription factors involved in cancer. The recent publications of his lab demonstrate a strong trajectory in understanding the structural basis of transcription factor binding to nucleosomes (e.g., OCT4-SOX2, MYC-MAX, CLOCK-BMAL1) and the mechanism of action of molecular glues like thalidomide. These studies highlight a shift toward therapeutic innovation through chemical biology, aiming to develop novel strategies for targeting 'undruggable' proteins in human diseases. Scientific Awards No specific awards listed in the provided text. Advising and Grants Thomä actively supervises a team of PhD students and postdoctoral researchers, including David Domjan, Laurin Tim Kanis, Alessandro Minafra, and Pierre Alexander Miranda Herrera. His lab is supported by institutional funding from EPFL and likely external grants related to cancer research, structural biology, and chemical biology, though specific grants are not mentioned. The lab’s interdisciplinary approach suggests collaboration with pharmaceutical and biotech partners. Labs and Teams The Thomä Lab, based at EPFL’s SV building, includes a multidisciplinary team of scientists, technical specialists, and administrative support. Key members include Fiona Bello (Technical Specialist), Regina Baur, Alexandra Bendel, Manuel Carminati, and others. The lab is structured around two main research pillars: Transcription Factors in Chromatin Biology and Ubiquitin Biology and Molecular Glues, reflecting its dual focus on fundamental mechanisms and therapeutic applications.
Michael Feig serves as Professor in the Department of Biochemistry & Molecular Biology at Michigan State University, leading the Feig Lab within the BioMolecular Science Gateway initiative. His research bridges computational modeling and molecular biology to investigate protein behavior in cellular contexts, with particular emphasis on molecular dynamics simulations and machine learning applications. His academic background includes: Ph.D. (1999) from the University of Houston M.S. (1994) from Technical University of Berlin Feig's research program focuses on computational biophysics of protein systems, specializing in molecular dynamics simulations of crowded cellular environments, bacterial microcompartments, and intrinsically disordered proteins. His lab develops advanced modeling techniques including coarse-grained approaches (COCOMO2) and machine learning frameworks to predict protein properties and conformational landscapes. Current work explores temperature-dependent structural ensembles, enzyme cargo loading mechanisms in engineered microcompartments, and biomolecular condensate physics under shear flow. Analysis of his 15 most recent publications (2024-2025) reveals three dominant research thrusts: (1) integration of deep learning with molecular dynamics for protein structure prediction, (2) engineering of bacterial microcompartments for synthetic biology applications, and (3) fundamental studies of macromolecular crowding effects on diffusion and phase separation. His work consistently emphasizes methodological innovation with biological relevance, notably through enhancements to the CHARMM simulation platform. His scientific recognition includes: Alfred P. Sloan Fellowship (2005) As principal investigator of the Feig Lab, he directs research teams in computational biophysics projects supported by active funding mechanisms. While specific grant details aren't provided, his continuous publication pipeline and lab infrastructure indicate sustained research support. His mentorship spans graduate students in the Cell & Molecular Biology Program, with recent work involving multi-institutional collaborations on bacterial microcompartment engineering and protein phase separation. The Feig Lab operates at the intersection of high-performance computing and molecular biology, maintaining strong connections with experimental groups for method validation. Current initiatives include developing generative models for temperature-dependent protein conformations and investigating cytoplasmic protein capture mechanisms in microcompartments, with potential applications in metabolic engineering and nanobiotechnology.
Douglas C. Hopkins is a Research Professor and Director of the Laboratory for Packaging Research in Electronic Energy Systems (PREES) at North Carolina State University's Department of Electrical and Computer Engineering. He joined the ECE faculty in 2011 and is affiliated with the FREEDM Systems Center and the Center for Additive Manufacturing and Logistics (CAMAL). He holds a Ph.D. in Electrical Engineering from Virginia Tech (1989). His research focuses on Very High-Frequency power electronics, Wide Band Gap (WBG) devices (GaN/SiC), advanced packaging, and solid-state protection systems . He has pioneered work in integrated power electronics, harsh-environment systems, and 3D power electronics integration. His leadership includes founding conferences such as the International Symposium on 3D Power Electronics Integration and Manufacturing (3D-PEIM) and the International Symposium on Advanced Power Electronics Packaging (APEPS). Prof. Hopkins has authored over 200 publications and co-founded DensePower, LLC as CEO/CTO. He serves as Associate Editor for the IEEE Journal of Emerging and Selected Topics in Power Electronics and holds editorial roles in multiple journals. His awards include the IMAPS Outstanding Educator Award (2013) and IMAPS Fellow (2007). He has held visiting appointments at the Army Research Lab, NASA, and Lawrence Livermore National Lab, and served as a National Academy of Sciences reviewer. His consulting firm, DCHopkins & Associates, LLC, provides engineering expertise in power electronics and packaging. Key Contributions: Director of PREES Lab and FREEDM Center member Co-founder of 3D-PEIM and APEPS symposiums IEEE PELS Technical Committee member (TC2, TC-6) Recipient of IMAPS Fellow and multiple conference recognitions
Stephen L. Bearne is a Professor in the Departments of Biochemistry and Molecular Biology and Chemistry at Dalhousie University, affiliated with the Faculty of Medicine. He has been a department member since 1996 and served as Department Head from 2012 to 2022. His research focuses on enzymology, enzyme catalysis, and protein engineering, with a particular emphasis on transition state analogues, enzyme inhibition mechanisms, and the chemical basis of disease-associated enzymes. His work integrates organic synthesis, biophysical techniques, and computational modeling to explore enzyme function and design inhibitors for therapeutic applications. Dr. Bearne holds a PhD from the University of Toronto and an MDCM from McGill University. His lab is part of the Protein Assembly Research Team and the BioActives CREATE Training Program. Current research themes include understanding carbon acid substrate catalysis in mandelate racemase, developing inhibitors for CTP synthase and racemases involved in diseases like cancer and neglected tropical infections, and proteomic tools for enzymatic activity profiling. His research leverages advanced techniques such as site-directed mutagenesis, isothermal titration calorimetry, NMR spectroscopy, and macroion mobility spectrometry. His lab supports equity, diversity, and inclusivity and has been funded by NSERC, CIHR, and other agencies. Recent publications highlight advancements in enzyme inhibition strategies, allosteric regulation mechanisms, and enzyme filamentation roles in metabolic pathways.
Fabian Pfrengle is a full Professor of Organic Chemistry at the Institute of Organic Chemistry , Department of Natural Sciences and Sustainable Resources , University of Natural Resources and Life Sciences Vienna (BOKU). He previously led research groups at the Max Planck Institute of Colloids and Interfaces (2013-2020) and worked at The Scripps Research Institute (2010-2013). Research Focus: His work bridges carbohydrate chemistry and plant biology , specializing in plant cell wall glycans and glycosyltransferases . He develops synthetic glycan arrays for enzyme characterization and investigates immune response triggering mechanisms in plants through oligosaccharide fragments . His projects include automated polysaccharide synthesis and liposome-based immune tolerance applications. Publication Trends: His 15 most recent articles emphasize chemical synthesis of sugar nucleotides , plant glycan arrays , and enzyme specificity analysis , reflecting his focus on carbohydrate engineering and plant immunity . Key subfields include UDP-sugar derivatization , Xylan structure-function relationships , and Glycosyltransferase profiling . Grants & Projects: Currently leads 5 major projects including Automated Algal Polysaccharide Synthesis (EU-funded, 2023-2028) and Synthetic Glycan Ligands for Plant Immune Receptors (FWF-funded, 2022-2026). His research also explores thrombocyte biology and Rhamnogalacturonan-II fragments with support from FWF and City of Vienna . Community Service: Serves on editorial boards ( Monatshefte für Chemie , 2021-present) and as reviewer for 12 journals including JACS Au , Nature Communications , and Angewandte Chemie . Member of professional societies: Gesellschaft Österreichischer Chemiker (2020), Deutscher Hochschulverband (2019), and Gesellschaft Deutscher Chemiker (2008).
Jeff S Abramson is a Professor of Physiology in the David Geffen School of Medicine at the University of California Los Angeles (UCLA). His research focuses on the structural and functional characterization of membrane transport proteins, particularly sugar transporters and mitochondrial channels. He maintains an active laboratory investigating the molecular mechanisms of cellular transport processes. Dr. Abramson's primary research interests center on membrane transport proteins, with particular emphasis on sugar symporters and voltage-dependent anion channels (VDACs). His work combines structural biology, biophysics, and biochemistry to understand the molecular mechanisms of transport, including conformational changes during transport cycles, substrate recognition, and regulation by membrane potential. His research has significant implications for understanding metabolic disorders, mitochondrial function, and potential therapeutic targets. Analysis of Dr. Abramson's publication record reveals a consistent focus on membrane protein structure-function relationships over the past two decades. His work demonstrates expertise in X-ray crystallography, cryo-electron microscopy, and functional assays to characterize transport proteins. Recent publications show increasing emphasis on mitochondrial biology, particularly VDAC structure and function, while maintaining his longstanding interest in sugar transport mechanisms. His research bridges fundamental biophysical principles with potential biomedical applications in metabolic diseases. Dr. Abramson has been awarded multiple NIH grants supporting his research, including the R35GM135175 grant titled 'Deciphering molecular details of cellular sugar transport and their roles in disease' (2020-2024), R01GM124783 'Functional and structural studies of unique pathogenic transporters involved in glycobiology' (2017-2021), and R01GM078844 'Structural and functional characterization of sugar transporters in health and disease' (2006-2020). As Principal Investigator, Dr. Abramson has mentored numerous graduate students and postdoctoral researchers. His laboratory has made significant contributions to understanding the structure-function relationships of membrane transport proteins through collaborations with researchers across multiple disciplines. The lab utilizes advanced techniques including X-ray crystallography, cryo-EM, electrophysiology, and computational modeling to address fundamental questions about membrane protein mechanisms. Dr. Abramson's laboratory is part of UCLA's broader research ecosystem focused on structural biology and membrane protein research. His work intersects with several research centers at UCLA including those focused on metabolic diseases and structural biology. The lab maintains active collaborations with researchers specializing in biophysics, computational modeling, and disease mechanisms to translate basic findings into potential biomedical applications.
Scott Garman is Professor of Biochemistry at UMass Amherst, focusing on structural biology of glycoproteins in human diseases. PhD from Harvard University. Research areas: Lysosomal enzyme mechanisms in storage diseases (Fabry, Schindler); Malaria surface protein structures; Antibody-receptor interactions. Utilizes X-ray crystallography to study enzyme mutations causing disease. Key findings: Determined structures of α-galactosidase (Fabry disease) and α-NAGAL (Schindler disease), revealing molecular bases for enzyme dysfunction. Developed models for enzyme trafficking and substrate processing. Laboratory: Investigates protein folding diseases and develops therapeutic strategies. Collaborates on malaria vaccine development and antibody engineering.
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Salvador Barraza-Lopez is a Professor of Physics at the University of Arkansas' College of Arts & Sciences. A theoretical physicist specializing in 2D materials, he developed discrete differential geometry approaches for strain effects in graphene and pioneered 2D ferroelectric research. As a DOE Early Career Awardee (2016) and MonArk NSF Quantum Foundry co-founder, he leads interdisciplinary collaborations across physics, materials science, and mathematics. PhD in Physics from University of Illinois-Urbana Champaign (2006) Postdoctoral work at Virginia Tech and Georgia Tech Established theory of structural transformations in 2D ferroelectrics His research spans quantum phase transitions in 2D systems, strain engineering, and topological materials. Three major review articles in Reports on Progress in Physics (2017, 2023) and Reviews of Modern Physics (2021) synthesize his work on mechanical, electronic, and optical properties of strained 2D materials. Recent publications focus on winding Berry dipoles in strained graphene, size-dependent ferroelectric transitions in homobilayers, and symmetry-breaking effects in moiré superlattices. Collaborations with Kai Chang (Beijing) and Stuart Parkin (MPI-Halle) demonstrate international impact. Awards: DOE Early Career Award (2016) Outstanding Mentor Recognition (2013) Young Investigator of the Year (2013) Mentored 2 NSF Graduate Fellows (Erin Farmer, Joseph Roll) and 3 Goldwater Scholars. Current group includes 2 undergraduates, 3 PhD students, and 2 postdocs. His theoretical frameworks enabled experimental collaborations with DOE labs and Max Planck Institute, securing $0.5M for Arkansas supercomputer upgrades (2024).
